Echothiophate Iodide Ophthalmic Solution
Brand names: Phospholine Iodide
Category: Ophthalmology
FDA status: Current · Last FDA update: Sep 1, 2026 · First posted: Sep 24, 2019 (in shortage 7 years) · 1 manufacturers, 1 listed presentations
As of Sep 1, 2026, the FDA lists Echothiophate Iodide Ophthalmic Solution as currently in shortage. Of 1 manufacturer presentations, 1 Available.
| Presentation & package NDC | Manufacturer | Availability | FDA note |
|---|---|---|---|
| Phospholine Iodide, Ophthalmic Solution, 0.125% (NDC 48102-053-05) NDC 48102-053-05 |
Fera Pharmaceuticals | Available | Available through limited distribution by Walgreens Specialty Pharmacy. |
Related medications in shortage
Other Ophthalmology medications currently on the FDA shortage list — useful context if you and your prescriber are weighing alternatives. Always confirm with your pharmacist.
Change log
Tracking began Oct 1, 2026. We check the FDA every 6 hours; any real change - a manufacturer moving from Limited to Available, a new recovery date, a new listing - shows up here with its date.
Cite this: “FDA drug-shortage status for Echothiophate Iodide Ophthalmic Solution (FDA data as of Sep 1, 2026). Shortage Watch, openFDA.”
Get an email when this record changes
One email, only when the FDA changes something for Echothiophate Iodide Ophthalmic Solution. You confirm by clicking a link first (double opt-in). No newsletter, no other mail.
Feeds instead of email: RSS or JSON. Unsubscribe anytime; see Privacy.
Embed a live status badge: /badge/echothiophate-iodide-ophthalmic-solution.svg
FDA data last synced Oct 1, 2026 (FDA record dated Sep 30, 2026).